>
Organization
Seattle Genetics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Seattle Genetics, Inc.

... Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its fourth quarter and ...
... Seattle Genetics, Inc. (Nasdaq:SGEN) today announced the publication of data from the ECHELON-1 phase ...
... consulting firm, for the facilitation of the acquisition of cannabis genetics (the "Genetics Agreement"). The core details of the amended agreement were originally announced on ...
... Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the 37th Annual ...
... protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E (MMAE), utilizing Seattle Genetics' proprietary technology. The ADC employs a linker system that is designed ...
... Seattle Genetics and Takeda have reported positive topline results from the Phase II ...
... SAN DIEGO—Last month, Seattle Genetics scored an ultrafast FDA nod for Adcetris in patients with newly ...
... grant MRSG-14-052-01. Diefenbach reports having received consulting fees and research funding from Seattle Genetics and Bristol-Myers Squibb, the manufacturers of the drugs used in this ...
... Advanced Hodgkin Lymphoma at ASH Annual Meeting SAN DIEGO - Seattle Genetics, Inc. (Nasdaq: SGEN) today highlighted data from the ECHELON-1 phase 3 clinical trial ...
... Adults in Relapsed Hodgkin Lymphoma to be Featured in Oral Presentation- Seattle Genetics, Inc. (Nasdaq:SGEN) today highlighted data from three ongoing clinical trials evaluating the ...
Subscribe now for full coverage on Seattle Genetics, Inc.
Start My Free Trial